Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.6910 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Jacqueline Liu und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Psoriasis, Dermatologic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Liu, J., Cices, A., Kaufman, B., Sanabria-Gonzalez, I., & Alexis, A. (2023). Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.6910
Vancouver
Liu J, Cices A, Kaufman B, Sanabria-Gonzalez I, Alexis A. Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.6910
BibTeX
@article{Liu2023,
author = {Liu, Jacqueline and Cices, Ahuva and Kaufman, Bridget and Sanabria-Gonzalez, Ingrid and Alexis, Andrew},
title = {Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.6910}
}
EUVIMED